Status:
RECRUITING
Cannabis Use and Outcomes in Black and White Patients With Cancer
Lead Sponsor:
State University of New York at Buffalo
Collaborating Sponsors:
University of Pennsylvania
Thomas Jefferson University
Conditions:
Cancer
Eligibility:
All Genders
21-99 years
Brief Summary
The goal of the observational study is to learn how black and white patients with solid tumor cancer use cannabis, opioids and tobacco. The investigators are using momentary ecological assessment thro...
Detailed Description
Using an observational design with momentary ecological assessment on a smartphone app (mEMA), The investigators propose a strong prospective cohort design with repeated-measures for 12 months regardi...
Eligibility Criteria
Inclusion
- 21 years or older
- Black or white race
- Solid tumor cancer within 3 years of enrollment
- Cannabis use of at least once a week or non cannabis use for 3 months
- experience pain but spend less than 50% in bed or chair
- Prescribed or take opioid for at least 30 days for pain
- Not pregnant or planning to become pregnant in the next 12 months
- English speaking
Exclusion
- Lymphoma, leukemia, and melanoma
- CBD only use
- Synthetic cannabis use in past 3 months = Prescribed Medically-prescribed synthetic cannabis (e.g., dronabinol \[Marinol, Syndros\], Epidiolex)
- race other than Black or White
Key Trial Info
Start Date :
March 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 30 2027
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06037681
Start Date
March 30 2023
End Date
March 30 2027
Last Update
October 30 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University at Buffalo
Buffalo, New York, United States, 14214
2
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19144
3
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19176